We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNNA icon
4526
Hennessy Advisors
HNNA
$79M
$159K ﹤0.01%
16,535
NGD
4527
DELISTED
New Gold Inc
NGD
$159K ﹤0.01%
150,508
PROF
4528
Profound Medical
PROF
$251M
$159K ﹤0.01%
10,870
SVM
4529
Silvercorp Metals
SVM
$2.67B
$159K ﹤0.01%
41,930
CMPI
4530
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$159K ﹤0.01%
40,260
-12
-0% -$62
CXDO icon
4531
Crexendo
CXDO
$214M
$158K ﹤0.01%
26,602
+8,836
+50% +$53.1K
EXK
4532
Endeavour Silver
EXK
$3.13B
$158K ﹤0.01%
38,654
KRBP
4533
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$158K ﹤0.01%
+1,724
New +$178K
GTPB
4534
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$158K ﹤0.01%
+16,195
New +$159K
REVH
4535
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$158K ﹤0.01%
16,274
OPRA
4536
Opera Ltd
OPRA
$1.78B
$157K ﹤0.01%
17,751
PETV
4537
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$157K ﹤0.01%
+57,836
New +$175K
HSTO
4538
DELISTED
Histogen Inc. Common Stock
HSTO
$157K ﹤0.01%
10,395
+1,733
+20% +$29.3K
PARA
4539
Banzai International
PARA
$5.54M
$156K ﹤0.01%
2
EVGN icon
4540
Evogene
EVGN
$9.34M
$155K ﹤0.01%
5,901
+3,228
+121% +$94.2K
RDCM icon
4541
Radcom
RDCM
$174M
$155K ﹤0.01%
13,668
ROI
4542
DELISTED
RiskOn International, Inc. Common Stock
ROI
$155K ﹤0.01%
+990
New +$139K
GNAC
4543
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
$155K ﹤0.01%
15,955
CHPM
4544
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
$154K ﹤0.01%
15,418
PED icon
4545
PEDEVCO
PED
$154M
$153K ﹤0.01%
5,195
TPHS
4546
DELISTED
Trinity Place Holdings Inc.com
TPHS
$153K ﹤0.01%
78,294
CMMB
4547
Chemomab Therapeutics
CMMB
$13.8M
$152K ﹤0.01%
+3,435
New +$209K
DESP
4548
DELISTED
Despegar.com
DESP
$152K ﹤0.01%
12,672
EPSN icon
4549
Epsilon Energy
EPSN
$178M
$152K ﹤0.01%
+23,688
New +$121K
SDPI
4550
DELISTED
Superior Drilling Products Inc.
SDPI
$152K ﹤0.01%
87,066

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.